Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2018 | Pages:
109 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report focuses on the global Next Generation Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Cancer Diagnostics development in United States, Europe and China.
In 2017, the global Next Generation Cancer Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
The key players covered in this study
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market segment by Type, the product can be split into
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Next Generation Cancer Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Next Generation Cancer Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Next Generation Cancer Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (2013-2025)
1.4.2 Next Generation Sequencing
1.4.3 qPCR & Multiplexing
1.4.4 DNA Microarrays
1.4.5 Other
1.5 Market by Application
1.5.1 Global Next Generation Cancer Diagnostics Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Next Generation Cancer Diagnostics Market Size
2.2 Next Generation Cancer Diagnostics Growth Trends by Regions
2.2.1 Next Generation Cancer Diagnostics Market Size by Regions (2013-2025)
2.2.2 Next Generation Cancer Diagnostics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Next Generation Cancer Diagnostics Market Size by Manufacturers
3.1.1 Global Next Generation Cancer Diagnostics Revenue by Manufacturers (2013-2018)
3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Next Generation Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Next Generation Cancer Diagnostics Key Players Head office and Area Served
3.3 Key Players Next Generation Cancer Diagnostics Product/Solution/Service
3.4 Date of Enter into Next Generation Cancer Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Next Generation Cancer Diagnostics Market Size by Type (2013-2018)
4.2 Global Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
5 United States
5.1 United States Next Generation Cancer Diagnostics Market Size (2013-2018)
5.2 Next Generation Cancer Diagnostics Key Players in United States
5.3 United States Next Generation Cancer Diagnostics Market Size by Type
5.4 United States Next Generation Cancer Diagnostics Market Size by Application
6 Europe
6.1 Europe Next Generation Cancer Diagnostics Market Size (2013-2018)
6.2 Next Generation Cancer Diagnostics Key Players in Europe
6.3 Europe Next Generation Cancer Diagnostics Market Size by Type
6.4 Europe Next Generation Cancer Diagnostics Market Size by Application
7 China
7.1 China Next Generation Cancer Diagnostics Market Size (2013-2018)
7.2 Next Generation Cancer Diagnostics Key Players in China
7.3 China Next Generation Cancer Diagnostics Market Size by Type
7.4 China Next Generation Cancer Diagnostics Market Size by Application
8 Japan
8.1 Japan Next Generation Cancer Diagnostics Market Size (2013-2018)
8.2 Next Generation Cancer Diagnostics Key Players in Japan
8.3 Japan Next Generation Cancer Diagnostics Market Size by Type
8.4 Japan Next Generation Cancer Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Next Generation Cancer Diagnostics Market Size (2013-2018)
9.2 Next Generation Cancer Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Next Generation Cancer Diagnostics Market Size by Type
9.4 Southeast Asia Next Generation Cancer Diagnostics Market Size by Application
10 India
10.1 India Next Generation Cancer Diagnostics Market Size (2013-2018)
10.2 Next Generation Cancer Diagnostics Key Players in India
10.3 India Next Generation Cancer Diagnostics Market Size by Type
10.4 India Next Generation Cancer Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Next Generation Cancer Diagnostics Market Size (2013-2018)
11.2 Next Generation Cancer Diagnostics Key Players in Central & South America
11.3 Central & South America Next Generation Cancer Diagnostics Market Size by Type
11.4 Central & South America Next Generation Cancer Diagnostics Market Size by Application
12 International Players Profiles
12.1 Cepheid
12.1.1 Cepheid Company Details
12.1.2 Company Description and Business Overview
12.1.3 Next Generation Cancer Diagnostics Introduction
12.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.1.5 Cepheid Recent Development
12.2 Koninklijke Philips N.V
12.2.1 Koninklijke Philips N.V Company Details
12.2.2 Company Description and Business Overview
12.2.3 Next Generation Cancer Diagnostics Introduction
12.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.2.5 Koninklijke Philips N.V Recent Development
12.3 F. Hoffmann-La Roche Ltd
12.3.1 F. Hoffmann-La Roche Ltd Company Details
12.3.2 Company Description and Business Overview
12.3.3 Next Generation Cancer Diagnostics Introduction
12.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.3.5 F. Hoffmann-La Roche Ltd Recent Development
12.4 Qiagen
12.4.1 Qiagen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Next Generation Cancer Diagnostics Introduction
12.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.4.5 Qiagen Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Next Generation Cancer Diagnostics Introduction
12.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.5.5 Novartis AG Recent Development
12.6 Abbott
12.6.1 Abbott Company Details
12.6.2 Company Description and Business Overview
12.6.3 Next Generation Cancer Diagnostics Introduction
12.6.4 Abbott Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.6.5 Abbott Recent Development
12.7 Thermo Fisher Scientific
12.7.1 Thermo Fisher Scientific Company Details
12.7.2 Company Description and Business Overview
12.7.3 Next Generation Cancer Diagnostics Introduction
12.7.4 Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.7.5 Thermo Fisher Scientific Recent Development
12.8 Opko Health
12.8.1 Opko Health Company Details
12.8.2 Company Description and Business Overview
12.8.3 Next Generation Cancer Diagnostics Introduction
12.8.4 Opko Health Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.8.5 Opko Health Recent Development
12.9 Myriad Genetics
12.9.1 Myriad Genetics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Next Generation Cancer Diagnostics Introduction
12.9.4 Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.9.5 Myriad Genetics Recent Development
12.10 Agilent Technologies
12.10.1 Agilent Technologies Company Details
12.10.2 Company Description and Business Overview
12.10.3 Next Generation Cancer Diagnostics Introduction
12.10.4 Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.10.5 Agilent Technologies Recent Development
12.11 GE Healthcare
12.12 PerkinElmer
12.13 Genomic Health
12.14 Illumina
12.15 Hologic
12.16 Almac Group
12.17 Janssen Global Services
12.18 Sysmex Corporation
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Next Generation Cancer Diagnostics Key Market Segments
Table Key Players Next Generation Cancer Diagnostics Covered
Table Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Next Generation Cancer Diagnostics Market Size Market Share by Type 2013-2025
Figure Next Generation Sequencing Figures
Table Key Players of Next Generation Sequencing
Figure qPCR & Multiplexing Figures
Table Key Players of qPCR & Multiplexing
Figure DNA Microarrays Figures
Table Key Players of DNA Microarrays
Figure Other Figures
Table Key Players of Other
Table Global Next Generation Cancer Diagnostics Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Next Generation Cancer Diagnostics Report Years Considered
Table Global Next Generation Cancer Diagnostics Market Size 2013-2025 (Million US$)
Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Next Generation Cancer Diagnostics Market Size by Regions 2013-2025 (Million US$)
Table Global Next Generation Cancer Diagnostics Market Size by Regions 2013-2018 (Million US$)
Table Global Next Generation Cancer Diagnostics Market Share by Regions 2013-2018
Figure Global Next Generation Cancer Diagnostics Market Share by Regions 2013-2018
Figure Global Next Generation Cancer Diagnostics Market Share by Regions 2018
Table Market Top Trends
Table Global Next Generation Cancer Diagnostics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Next Generation Cancer Diagnostics Market Share by Manufacturers (2013-2018)
Figure Global Next Generation Cancer Diagnostics Market Share by Manufacturers in 2018
Table Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Next Generation Cancer Diagnostics Product/Solution/Service
Table Date of Enter into Next Generation Cancer Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table Global Next Generation Cancer Diagnostics Market Size Share by Type (2013-2018)
Figure Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2013-2018)
Table Global Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table Global Next Generation Cancer Diagnostics Market Size Share by Application (2013-2018)
Figure Global Next Generation Cancer Diagnostics Market Size Market Share by Application (2013-2018)
Figure Global Next Generation Cancer Diagnostics Revenue Market Share by Application in 2017
Figure United States Next Generation Cancer Diagnostics Market Size 2013-2018 (Million US$)
Table United States Key Players Next Generation Cancer Diagnostics Revenue (2017-2018) (Million US$)
Table United States Key Players Next Generation Cancer Diagnostics Market Share (2017-2018)
Table United States Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table United States Next Generation Cancer Diagnostics Market Share by Type (2013-2018)
Table United States Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table United States Next Generation Cancer Diagnostics Market Share by Application (2013-2018)
Figure Europe Next Generation Cancer Diagnostics Market Size 2013-2018 (Million US$)
Table Europe Key Players Next Generation Cancer Diagnostics Revenue (2017-2018) (Million US$)
Table Europe Key Players Next Generation Cancer Diagnostics Market Share (2017-2018)
Table Europe Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table Europe Next Generation Cancer Diagnostics Market Share by Type (2013-2018)
Table Europe Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table Europe Next Generation Cancer Diagnostics Market Share by Application (2013-2018)
Figure China Next Generation Cancer Diagnostics Market Size 2013-2018 (Million US$)
Table China Key Players Next Generation Cancer Diagnostics Revenue (2017-2018) (Million US$)
Table China Key Players Next Generation Cancer Diagnostics Market Share (2017-2018)
Table China Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table China Next Generation Cancer Diagnostics Market Share by Type (2013-2018)
Table China Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table China Next Generation Cancer Diagnostics Market Share by Application (2013-2018)
Figure Japan Next Generation Cancer Diagnostics Market Size 2013-2018 (Million US$)
Table Japan Key Players Next Generation Cancer Diagnostics Revenue (2017-2018) (Million US$)
Table Japan Key Players Next Generation Cancer Diagnostics Market Share (2017-2018)
Table Japan Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table Japan Next Generation Cancer Diagnostics Market Share by Type (2013-2018)
Table Japan Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table Japan Next Generation Cancer Diagnostics Market Share by Application (2013-2018)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Next Generation Cancer Diagnostics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Next Generation Cancer Diagnostics Market Share (2017-2018)
Table Southeast Asia Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Next Generation Cancer Diagnostics Market Share by Type (2013-2018)
Table Southeast Asia Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Next Generation Cancer Diagnostics Market Share by Application (2013-2018)
Figure India Next Generation Cancer Diagnostics Market Size 2013-2018 (Million US$)
Table India Key Players Next Generation Cancer Diagnostics Revenue (2017-2018) (Million US$)
Table India Key Players Next Generation Cancer Diagnostics Market Share (2017-2018)
Table India Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table India Next Generation Cancer Diagnostics Market Share by Type (2013-2018)
Table India Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table India Next Generation Cancer Diagnostics Market Share by Application (2013-2018)
Figure Central & South America Next Generation Cancer Diagnostics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Next Generation Cancer Diagnostics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Next Generation Cancer Diagnostics Market Share (2017-2018)
Table Central & South America Next Generation Cancer Diagnostics Market Size by Type (2013-2018) (Million US$)
Table Central & South America Next Generation Cancer Diagnostics Market Share by Type (2013-2018)
Table Central & South America Next Generation Cancer Diagnostics Market Size by Application (2013-2018) (Million US$)
Table Central & South America Next Generation Cancer Diagnostics Market Share by Application (2013-2018)
Table Cepheid Company Details
Table Cepheid Revenue in Next Generation Cancer Diagnostics Business (2013-2018) (Million US$)
Figure Cepheid Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Cepheid Recent Development
Table Koninklijke Philips N.V Company Details
Table Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Koninklijke Philips N.V Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Koninklijke Philips N.V Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure F. Hoffmann-La Roche Ltd Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table F. Hoffmann-La Roche Ltd Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Qiagen Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Qiagen Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Novartis AG Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Novartis AG Recent Development
Table Abbott Company Details
Table Abbott Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Abbott Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Abbott Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Thermo Fisher Scientific Recent Development
Table Opko Health Company Details
Table Opko Health Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Opko Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Opko Health Recent Development
Table Myriad Genetics Company Details
Table Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Myriad Genetics Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Myriad Genetics Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2013-2018)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2013-2018)
Table Agilent Technologies Recent Development
Table GE Healthcare Company Details
Table PerkinElmer Company Details
Table Genomic Health Company Details
Table Illumina Company Details
Table Hologic Company Details
Table Almac Group Company Details
Table Janssen Global Services Company Details
Table Sysmex Corporation Company Details
Table Global Next Generation Cancer Diagnostics Market Size by Regions (Million US$) 2018-2025
Figure Global Next Generation Cancer Diagnostics Market Size Share by Regions (2018-2025)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Regions in 2025
Figure United States Next Generation Cancer Diagnostics Market Size Forecast (2018-2025)(Million USD)
Figure Europe Next Generation Cancer Diagnostics Market Size Forecast (2018-2025)(Million USD)
Figure China Next Generation Cancer Diagnostics Market Size Forecast (2018-2025)(Million USD)
Figure Japan Next Generation Cancer Diagnostics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Forecast (2018-2025)(Million USD)
Figure India Next Generation Cancer Diagnostics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Next Generation Cancer Diagnostics Market Size Forecast (2018-2025)(Million USD)
Table Global Next Generation Cancer Diagnostics Market Size by Product (2018-2025) (Million US$)
Figure Global Next Generation Cancer Diagnostics Market Size by Product (2018-2025)
Figure Global Next Generation Cancer Diagnostics Market Size by Product in 2025
Table Global Next Generation Cancer Diagnostics Market Size by Application (2018-2025) (Million US$)
Figure Global Next Generation Cancer Diagnostics Market Size by Application (2018-2025)
Figure Global Next Generation Cancer Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
